International Journal of Drug Policy
Volume 16 , Pages 58-66 , December 2005

Interventions to reduce the sexual risk behaviour of injecting drug users

  • Don C. Des Jarlais

      Affiliations

    • Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, First Ave. at 16th St., New York, NY 10003, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 212 387 3803; fax: +1 212 387 3897.
    • ,
  • Salaam Semaan

      Affiliations

    • National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA
    • Tel.: +1 404 639 8870.

Received 11 January 2005 ,Revised 4 February 2005 ,Accepted 6 February 2005.

References 

  1. Bandura A. Social cognitive theory and exercise of control over HIV infection. In:  Peterson J,  DiClemente R editor. Preventing AIDS: theory and practice of behavioral interventions. New York: Plenum Press; 1993;
  2. Becker MH, Joseph JG. The health belief model and personal health behavior. Thorofare, New Jersey: Slack; 1974;
  3. Booth R, Watters J. How effective are risk reduction interventions targeting injection drug users?. AIDS. 1994;8:1515–1524
  4. In:  Brown BS,  Beschner GM editor. Handbook on risk of AIDS: injection drug users and sexual partners. Westport, CT: Greenwood Press; 1993;
  5. In:  Cooper H,  Hedges L editor. The handbook of research synthesis. New York: Russell Sage Foundation; 1994;
  6. Coyle S, Boruch R, Turner D. Randomized and observational approaches to evaluating the effectiveness of AIDS prevention programs. In:  Coyle S,  Boruch R editor. Evaluating AIDS prevention programs at 125–194. Washington, DC: National Academy Press; 1991;
  7. Cross J, Saunders C, Bartelli D. The effectiveness of educational and needle exchange programs: a meta-analysis of HIV prevention strategies for injecting drug users. Quality and Quantity. 1998;32:165–180
  8. Des Jarlais DC, Chamberland ME, Yancovitz SR, Weinberg P, Friedman SR. Heterosexual partners: a large risk group for AIDS. Lancet. 1984;8415(ii):1346–1347
  9. Des Jarlais DC, Friedman SR. Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done. Public Health Reports. 1998;113(Supplement 1):182–188
  10. Des Jarlais DC, Friedman SR, Friedmann P, Wenston J, Sotheran JL, Choopanya K, et al. HIV/AIDS-related behavior change among injecting drug users in different national settings. AIDS. 1995;6:611–617
  11. Des Jarlais DC, Hagan H, Friedman SR. Epidemiology and emerging public health perspectives. In:  Lowinson JH,  Ruiz P,  Millman RB,  Langrod JG editor. Substance abuse. A comprehensive textbook. 3rd ed.. Baltimore, Maryland: Williams & Wilkins; 1997;p. 591–597
  12. Des Jarlais DC, Hagan HH, Friedman SR, Friedman P, Goldberg D, Frischer M, et al. Maintaining low HIV seroprevalence in populations of injecting drug users. Journal of the American Medical Association. 1995;274(15):1226–1231
  13. Des Jarlais DC, Perlis T, Poznyak V. Characteristics of injecting drug users (IDUs) in different regions of the world: WHO Phase II Study. In: Paper presented at the international conference on the reduction of harm. Melbourne, Australia. 2004;
  14. Desenclos JC, Papaevangelou G, Ancelle-Park R. Knowledge of HIV serostatus and preventive behavior among European injecting drug users. AIDS. 1993;7:1371–1377
  15. Doll L. Epidemiology of HIV-related behaviors in risk populations. In: Paper presented at the proceedings on the NIH consensus development conference on interventions to prevent HIV risk behaviors. Bethesda, MD, United States. 1997;
  16. Eke A, Peersman G, Semaan S, Hylton K, Kiiti N, Sweat M. Acquisition and review of non-U.S.-based HIV risk reduction intervention studies. Journal of Acquired Immune Deficiency Syndromes. 2002;30(Supplement 1):S51–S55
  17. Elwy A, Hart G, Hawkes S, Petticrew M. Effectiveness of interventions to prevent sexually transmitted infections and human immunodeficiency virus in heterosexual men. Archives of Internal Medicine. 2002;162(16):1818–1830
  18. Fleiss J. Measures of effect size for categorical data. In:  Cooper H,  Hedges L editor. The handbook of research synthesis. New York: Russel Sage Foundation; 1994;p. 245–260
  19. Fletcher R, Fletcher S, Wagner E. Clinical epidemiology. Baltimore: Williams & Wilkins; 1988;
  20. Friedman SR, Des Jarlais DC, Ward TP. Social models for changing risk behavior. In:  DiClemente R,  Peterson J editor. Preventing AIDS: theory and practice of behavioral interventions. New York: Plenum; 1994;p. 95–116
  21. Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS. 2001;15(11):1329–1341
  22. Hedges L, Veva J. Fixed- and random-effects models in meta-analysis. Psychological Methods. 1998;3:486–504
  23. Johnson WD, Hedges LV, Ramirez G, Semaan S, Norman LR, Sogolow E, et al. HIV prevention research for men who have sex with men: A systematic review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes. 2002;30:S118–S129
  24. Johnson W, Semaan S, Hedges L, Ramirez G, Mullen PD, Sogolow E. A protocol for the analytical aspects of a systematic review of HIV prevention research. Journal of Acquired Immune Deficiency Syndromes. 2002;30(Supplement 1):S62–S72
  25. Ksobiech K. A meta-analysis of needle sharing, lending, and borrowing behaviors of needle exchange program attenders. AIDS Education and Prevention. 2003;15(3):257–268
  26. Metzger D, Woody G, McLellan A, O’Brien C, Druley P, Navaline H, et al. HIV seroconversion among IDUs in and out-of-treatment: an 18-month prospective follow-up. AIDS. 1993;6(9):1049–1056
  27. Needle RH, Burrows D, Friedman SR, Dorabjee J, Touze G, Badrieva L, et al. Effectiveness of community-based outreach in preventing HIV/AIDS among injecting drug users. International Journal of Drug Policy. 2005;(Supplement):
  28. Neumann MS, Johnson WD, Semaan S, Flores SA, Peersman G, Hedges LV, et al. Review and meta-analysis of HIV prevention intervention research for heterosexual adult populations in the United States. Journal of Acquired Immune Deficiency Syndromes. 2002;30(Supplement):S106–S117
  29. Petitti D. Meta-analysis, decision analysis, and cost-effectiveness analysis. New York: Oxford University Press; 1994;
  30. Semaan S, Des Jarlais DC, Sogolow E, Johnson W, Hedges L, Ramirez G, et al. A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. Journal of Acquired Immune Deficiency Syndromes. 2002;30(Supplement 1):S73–S93
  31. In:  Stimson GV,  Des Jarlais DC,  Ball A editor. Drug injecting and HIV infection: global dimensions and local responses. London: UCL Press; 1998;
  32. UNAIDS/WHO, (2003). AIDS epidemic update. Geneva, Switzerland.
  33. UNODCP. (2004). World Drug Report 2004. Reference Group on the Prevention and Care of HIV/AIDS Among Injecting Drug Users, 2002 (Vol. 1, Chap. 1.3, p. 48). http://www.unodc.org/pdf/WDR_2004/Chap1_injecting_drugs.pdf.
  34. van Empelen P, Kok G, van Kesteren NM, van den Borne B, Bos AE, Schaalma HP. Effective methods to change sex-risk among drug users: a review of psychosocial interventions. Social Science and Medicine. 2003;57(9):1593–1608
  35. Vanichseni S, Choopanya K, Des Jarlais DC, Plangsringarm K, Sonchai W, Carballo M, et al. HIV testing and sexual behavior among intravenous drug users in Bangkok, Thailand. Journal of Acquired Immune Deficiency Syndromes. 1992;5:1119–1123
  36. Vanichseni S, Des Jarlais DC, Choopanya K, Friedmann P, Wenston J, Sonchai W, et al. Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United States. AIDS. 1993;7:887–891
  37. Weinhardt L, Carey M, Johnson B, Bickham N. Effects of HIV counseling and testing on sexual risk behavior: A meta-analytic review of published research, 1985–1997. American Journal of Public Health. 1999;89(9):1397–1404
  38. Wiebel W, Jimenez A, Johson W, Ouellet L, Jovanovic B, Lampinen T, et al. Risk behavior and HIV seroincidence among out-of-treatment IDUs: four-year prospective study. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1996;12(3):282–289

PII: S0955-3959(05)00079-4

doi: 10.1016/j.drugpo.2005.02.005

International Journal of Drug Policy
Volume 16 , Pages 58-66 , December 2005

Article Tools